The past week finished on a somewhat bad note as the Bureau of Economic Analysis' "advanced" reading of U.S. GDP growth came in at 2.2%, markedly below economists' forecasts. However, even that wasn't enough to derail a week of strong earnings reports, which provided a nice tailwind for the markets that held through even that late-week disappointment. Among the big earnings headlines were sizeable beats from tech/consumer powerhouses Apple and Amazon.com
By the time the dust had settled on Friday, the Dow Jones Industrial Average
The week's big winners
Earnings reports were driving most of the big moves in the market over the past week, but for many companies, the moves were a lot more about projections of what's ahead as opposed to a rehashing of the money that the company earned last quarter. That was exactly the case for Cirrus Logic
For supercomputer specialist Cray
But that wasn't all for Cray during the week. The company also got a shot in the arm after Intel agreed to pay $140 million for networking technology from the company. The deal will significantly strengthen Cray's balance sheet and helped make it a week that the company's shareholders won't quickly forget.
Top 3 Performing Russell 3000 Companies
Weekly Price Change
Source: S&P Capital IQ. Weekly price change is April 20-April 27. Includes only companies with a market cap of $250 million or higher.
Joining in on the big gains during the week were Incyte
For Incyte, the future is still where the payoff is for investors, as the bottom line remains in the red. For the first quarter, though, the per-share loss of $0.36 was less than the $0.46 loss Wall Street expected. More importantly, however, the company's first commercial product, Jakafi, appears to be progressing well after being approved in November. Incyte shipped $25.1 million of Jakafi to specialty pharmacies during the quarter, but because of the way it's accounting for sales, it recorded $19.3 million in product revenue. The company also increased its revenue guidance for 2012 thanks to the previously announced $40 million milestone payment from Novartis.
For Amazon, meanwhile, solid growth sent shares soaring. Investments that the company has been making to help drive growth hurt the bottom-line comparison to last year. However, investors cheered the 34% jump in sales and the fact that the $0.28 in per-share earnings clobbered the $0.07 that Wall Street was expecting.
By week's end, Incyte had tacked on 18%, while Amazon jumped more than 19%.
That's it for this week's top-performers recap. If you're looking for some ideas for strong outperformers for the rest of year, The Motley Fool has created a free report titled "The Motley Fool's Top Stock for 2012." In it, my fellow Fools reveal a top pick that's poised for explosive growth ahead. Get instant access -- it's free.
The Motley Fool owns shares of Amazon.com, Cirrus Logic, Apple, and Intel. Motley Fool newsletter services have recommended buying shares of Apple, Intel, Novartis, and Amazon.com and creating a bull call spread position in Apple. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
Fool contributor Matt Koppenheffer owns shares of Intel but has no financial interest in any of the other companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter, @KoppTheFool, or on Facebook. The Fool’s disclosure policy prefers dividends over a sharp stick in the eye.